TNGX — TANGO THERAPEUTICS INC

Ownership history in GILEAD SCIENCES, INC.  ·  4 quarters on record

This page tracks every 13F SEC filing in which GILEAD SCIENCES, INC. reported a position in TANGO THERAPEUTICS INC (TNGX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
2.28% (2025 Q3)
Avg. % of fund
1.44%
First filed
2024 Q4
Last filed
2025 Q3
Quarters held
4
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 UNCHANGED 4,854,443 — 0% 2.28% $40.8M $8.40
2025 Q2 UNCHANGED 4,854,443 — 0% 1.94% $24.85B $5.12
2025 Q1 UNCHANGED 4,854,443 — 0% 0.56% $6.65B $1.37
2024 Q4 INITIATED 4,854,443 — — 0.97% $15.00B $3.09
% of Fund (quarterly)    TNGX price (monthly, adj. close)

Other funds also holding TNGX

As of 2025 Q4 — sorted by position size

TRV GP IV, LLC 3Y 27.35% TCG Crossover Management, LLC 3Y 3.74% Caligan Partners LP 3Y 2.72% Logos Global Management LP 3Y 2.25% Siren, L.L.C. 2.16% ACUTA CAPITAL PARTNERS, LLC 3Y 7Y 1.7% Seven Fleet Capital Management LP 1.45% Vivo Capital, LLC 3Y 7Y 1.23% TRV GP VI, LLC 1.16% Nantahala Capital Management, LLC 3Y 7Y 1.05%
← Back to GILEAD SCIENCES, INC. Holdings